Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 22, 2026 18:07 UTC |
Bacic William KTrustee of the Fund
|
PurchaseCommon Shares of Beneficial Interest | 308 | $11.48 | $3,535.84 |
DisclosureSEC source: 0002032340-26-000007 · primary_doc.xml · nonDerivative · entry 1 Bacic William K · CIK 0002032340 · Trustee of the Fund 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,294 Read SEC document |
| May 06, 2026 Filed May 7, 2026 16:36 UTC |
Hurtsellers ChristineDirector
|
PurchaseCommon Shares of Beneficial Interest | 0.394 | $11.61 | $4.57 |
DisclosureSEC source: 0001481859-26-000007 · primary_doc.xml · nonDerivative · entry 4 Hurtsellers Christine · CIK 0001481859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,037.394 Read SEC document |
| May 06, 2026 Filed May 7, 2026 16:36 UTC |
Hurtsellers ChristineDirector
|
PurchaseCommon Shares of Beneficial Interest | 2 | $11.61 | $23.22 |
DisclosureSEC source: 0001481859-26-000007 · primary_doc.xml · nonDerivative · entry 3 Hurtsellers Christine · CIK 0001481859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,037 Read SEC document |
| May 06, 2026 Filed May 7, 2026 16:36 UTC |
Hurtsellers ChristineDirector
|
PurchaseCommon Shares of Beneficial Interest | 835 | $11.57 | $9,660.20 |
DisclosureSEC source: 0001481859-26-000007 · primary_doc.xml · nonDerivative · entry 2 Hurtsellers Christine · CIK 0001481859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,035 Read SEC document |
| May 06, 2026 Filed May 7, 2026 16:36 UTC |
Hurtsellers ChristineDirector
|
PurchaseCommon Shares of Beneficial Interest | 200 | $11.56 | $2,312.00 |
DisclosureSEC source: 0001481859-26-000007 · primary_doc.xml · nonDerivative · entry 1 Hurtsellers Christine · CIK 0001481859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200 Read SEC document |
| January 27, 2026 Filed Jan 27, 2026 21:58 UTC |
Phelan Kenneth JDirector
|
PurchaseCommon Shares of Beneficial Interest | 905 | $11.10 | $10,045.50 |
DisclosureSEC source: 0001779467-26-000010 · primary_doc.xml · nonDerivative · entry 1 Phelan Kenneth J · CIK 0001779467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 905 F1 · security: This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing. F1 · shares: This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing. F1 · price: This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing. F1 · balance_after: This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing. Read SEC document |
| April 08, 2025 Filed Apr 9, 2025 15:42 UTC |
Wright Thomas RoweDirector
|
PurchaseCommon Shares of Beneficial Interest | 1,139 | $9.70 | $11,049.55 |
DisclosureSEC source: 0001950731-25-000040 · primary_doc.xml · nonDerivative · entry 1 Wright Thomas Rowe · CIK 0001669193 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,139 Read SEC document |
| January 14, 2025 Filed Jan 15, 2025 21:31 UTC |
Bacic William KTrustee of the Fund
|
Purchasecommon shares of beneficial interest | 986 | $10.33 | $10,185.38 |
DisclosureSEC source: 0001992593-25-000002 · primary_doc.xml · nonDerivative · entry 1 Bacic William K · CIK 0002032340 · Trustee of the Fund 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 986 Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 15:53 UTC |
McKee Noni EllisonTrustee of the Fund
|
Purchasecommon shares of beneficial ownership | 1,070 | $10.54 | $11,277.80 |
DisclosureSEC source: 0002048097-24-000005 · primary_doc.xml · nonDerivative · entry 1 Ellison Noni L · CIK 0001840857 · Trustee of the Fund 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,252 Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 13:20 UTC |
Garfield DeanDirector
|
PurchaseCommon Shares of Beneficial Interest | 1,381.252 | $11.63 | $16,063.96 |
DisclosureSEC source: 0001561793-24-000002 · primary_doc.xml · nonDerivative · entry 1 Garfield Dean · CIK 0001947228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,381.252 Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 15:32 UTC |
McKee Noni EllisonDirector
|
PurchaseCommon Shares of Beneficial Interest | 1,153 | $9.56 | $11,022.68 |
DisclosureSEC source: 0001561793-23-000018 · primary_doc.xml · nonDerivative · entry 1 Ellison Noni L · CIK 0001840857 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,153 Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 12:47 UTC |
PRUCHANSKY STEVEN RTrustee of the Fund
|
Salecommon shares of beneficial interest | 2,014 | $12.57 | $25,315.98 |
DisclosureSEC source: 0001228616-22-000031 · primary_doc.xml · nonDerivative · entry 1 PRUCHANSKY STEVEN R · CIK 0001223427 · Trustee of the Fund 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589.8528 Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 16:37 UTC |
RATHKE FRANCES GTrustee of the Fund
|
Purchasecommon shares of beneficial interest | 910 | $10.98 | $9,992.16 |
DisclosureSEC source: 0001228616-20-000034 · primary_doc.xml · nonDerivative · entry 1 RATHKE FRANCES G · CIK 0001226477 · Trustee of the Fund 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 19:11 UTC |
MCCLELLAN HASSELL HTrustee of the Fund
|
Salecommon shares of beneficial interest | 64 | $16.05 | $1,027.48 |
DisclosureSEC source: 0001228616-16-000084 · primary_doc.xml · nonDerivative · entry 1 MCCLELLAN HASSELL H · CIK 0001489944 · Trustee of the Fund 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 808.012 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.